Amanda Micklus
Principal Analyst
Principal Analyst
Connecticut, USA
+20 year(s) experience
With a focus on research and analysis of corporate strategy and deal-making, Amanda provides analysis of market-moving events that influence business development at leading companies.
Her particular areas of expertise include big pharma licensing and immuno-oncology deal-making, R&D strategies and pharma diversification.
Before joining Informa in 2005, Amanda worked as a market research analyst at specialty pharmaceutical company Purdue Pharma and had a previous role as a medical librarian/information searcher.
She has a Bachelor of Science degree in Chemistry-Business from the University of Scranton, and a Master of Science in Library and Information Science from Long Island University.
HBW Insight : コンシューマーヘルスケア産業のニュース
13 Jun 2019
The Cosmetic Ingredient Review’s newly figured margins of safety for single- and multi-paraben use in cosmetic products are dramatically lower than previous MOSs that informed the Expert Panel’s 2008 “safe as used” conclusions. Whether the panel still deems the MOSs sufficiently protective is the question going into the group’s Sept. 24-25 meeting.
Rose Sheet: 世界の化粧品規制＆サプリメント業界ニュース
By Ryan Nelson 22 Aug 2018
The agency’s survey of eye-area cosmetics marketed as free of traditional preservatives doesn’t raise any obvious red flags. However, it does point to a possible contamination source and suggests “the limits of preservative activity in cosmetics.”
Topic fda
Pink Sheet: 世界の薬事規制と...
18 Oct 2018
Pink Sheet: 世界の薬事規制と...
01 Jun 2017
Pink Sheet: 世界の薬事規制と...
01 Jun 2017